CompletedPhase 1NCT04537351

The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cynata Therapeutics Limited
Principal Investigator
Jolanta Airey, MD, M.D
Cynata Therapeutics Limited
Intervention
CYP-001(biological)
Enrollment
14 enrolled
Eligibility
18 years · All sexes
Timeline
20202022

Study locations (5)

Collaborators

Cerebral Palsy Alliance

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04537351 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials